Corient Private Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Corient Private Wealth’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.3M	Sell	52,849 -56,173	-52%	-$7.01M	0.01%	776
2025 Q4	$13.3M	Buy	109,022 +70,319	+182%	+$8.06M	0.01%	685
2025 Q3	$3.88M	Sell	38,703 -4,437	-10%	-$400K	0.01%	801
2025 Q2	$3.58M	Sell	43,140 -14,439	-25%	-$1.15M	﹤0.01%	808
2025 Q1	$4.67M	Sell	57,579 -28,167	-33%	-$2.52M	0.01%	704
2024 Q4	$7.46M	Sell	85,746 -20,259	-19%	-$1.96M	0.01%	593
2024 Q3	$10.5M	Sell	106,005 -17,909	-14%	-$1.76M	0.02%	551
2024 Q2	$11.5M	Sell	123,914 -19,481	-14%	-$1.75M	0.02%	499
2024 Q1	$13.6M	Buy	143,395 +17,218	+14%	+$1.6M	0.02%	461
2023 Q4	$11.3M	Buy	126,177 +22,902	+22%	+$1.7M	0.02%	489
2023 Q3	$7.54M	Sell	103,275 -12,259	-11%	-$979K	0.02%	542
2023 Q2	$9.61M	Buy	115,534 +31,735	+38%	+$2.65M	0.02%	482
2023 Q1	$6.39M	Buy	83,799 +81,043	+2,941%	+$6.72M	0.02%	527
2022 Q4	$229K	Buy	+2,756	New	+$223K	﹤0.01%	1442

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Corient Private Wealth's XBI Position: Q1 2026 in Review

Corient Private Wealth reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 52% in Q1 2026, selling an estimated $7.01M and leaving 52,849 shares worth $6.3M. The position accounts for 0.01% of the portfolio, ranked #776.

Corient Private Wealth first reported a position in XBI in Q4 2022 and has held it in 14 quarters since. The position peaked at $13.6M in Q1 2024. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Corient Private Wealth held 52,849 shares of State Street SPDR S&P Biotech ETF worth $6.3M as of Q1 2026.
Corient Private Wealth sold 56,173 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $7.01M.
State Street SPDR S&P Biotech ETF made up 0.01% of Corient Private Wealth's portfolio in Q1 2026, its #776 holding.
Corient Private Wealth first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and has held it in 14 quarters since.
Corient Private Wealth's State Street SPDR S&P Biotech ETF position peaked at $13.6M in Q1 2024.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.